eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2017-12-21 10 4 2045 2050 10.13005/bpj/1326 18034 article Mohammed Sami Kadhim 1 Department of Basic Science, College of Dentistry, University of Baghdad, Iraq. Polycystic ovary syndrome (PCOS) is one of the most intricacy endocrine defect that affecting approximate 10 percent of female in the procreation age. This study aimed to estimate the concentration value of ghrelin in non-obese polycystic ovary syndrome females during menstrual cycle day 2. This study was conducted at Baghdad teaching hospital, from April 2015 until October 2016. Serum ghrelin, LH, FSH concentration were measured in 40 non-obese PCOS women and 40 healthy women during menstrual cycle day 2. The results indicates high significant increases (P ˂ 0.001) in mean of Ghrelin, LH and FSH in non-obese PCOS female group when compared with healthy female during day 2 menstrual cycle. It was concluded that ghrelin is a potential biomarker for diagnosis of PCOS. https://biomedpharmajournal.org/vol10no4/serum-ghrelin-lh-and-fsh-concentrations-during-menstrual-cycle-in-non-obese-pcos-women-compared-to-healthy-women/ Serum ghrelin LH and FSH concentrations non-obese PCOS women